Appili Therapeutics Inc. (APLIF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 813.74 Thousand CAD | -41.22% |
| 2023 | 1.38 Million CAD | -0.45% |
| 2022 | 1.39 Million CAD | 9473.71% |
| 2021 | -14.83 Thousand CAD | -107.45% |
| 2020 | 199.1 Thousand CAD | 1061.21% |
| 2019 | -20.71 Thousand CAD | -17.23% |
| 2018 | -17.67 Thousand CAD | -68.21% |
| 2017 | -10.5 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 333.87 Thousand CAD | 9799.91% |
| 2024 FY | 813.74 Thousand CAD | -41.22% |
| 2024 Q3 | 475 Thousand CAD | 42.27% |
| 2024 Q4 | 8478.00 CAD | -98.22% |
| 2024 Q1 | -3442.00 CAD | -101.04% |
| 2023 Q1 | -1549.00 CAD | 50.32% |
| 2023 Q4 | 332.55 Thousand CAD | 21596.57% |
| 2023 FY | 1.38 Million CAD | -0.45% |
| 2023 Q3 | -1547.00 CAD | -0.06% |
| 2023 Q2 | -1546.00 CAD | 0.19% |
| 2022 Q2 | -3214.00 CAD | -3.31% |
| 2022 FY | 1.39 Million CAD | 9473.71% |
| 2022 Q4 | -3118.00 CAD | -100.22% |
| 2022 Q3 | 1.39 Million CAD | 43369.57% |
| 2022 Q1 | -3111.00 CAD | 17.74% |
| 2021 FY | -14.83 Thousand CAD | -107.45% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q4 | -3782.00 CAD | 0.0% |
| 2020 FY | 199.1 Thousand CAD | 1061.21% |
| 2020 Q4 | - CAD | -100.0% |
| 2020 Q3 | 199.1 Thousand CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 FY | -20.71 Thousand CAD | -17.23% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2018 FY | -17.67 Thousand CAD | -68.21% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2017 FY | -10.5 Thousand CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 94.575% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -26132.914% |
| SQZ Biotechnologies Company | 9.79 Million USD | 91.691% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 93.048% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 99.317% |
| Mesoblast Limited | -35.16 Million USD | 102.314% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 2482.855% |
| Genus plc | 178.7 Million USD | 99.545% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -98.395% |
| Marizyme, Inc. | 457.7 Thousand USD | -77.789% |
| ContraFect Corporation | -154 Thousand USD | 628.406% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 7497.682% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 1727.49% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -960.102% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -1138.049% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 309.998% |
| MultiCell Technologies, Inc. | 49.32 USD | -1649829.035% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 97.979% |
| EV Biologics, Inc. | 48.9 Thousand USD | -1564.1% |
| Q BioMed Inc. | -8988.00 USD | 9153.683% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 97.12% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 5375.836% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 99.63% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -1062.493% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 754.92% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -1207.725% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 16532.653% |
| Arch Therapeutics, Inc. | -2439.00 USD | 33463.879% |
| IMV Inc. | -962.29 Thousand USD | 184.563% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -479.178% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 934.482% |
| GB Sciences, Inc. | -624.00 USD | 130507.853% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 1045.907% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.989% |
| Halberd Corporation | -208.00 USD | 391323.558% |
| Enzolytics Inc. | 30.7 Thousand USD | -2549.945% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | 40.04% |
| SYBLEU INC | 11.69 Thousand USD | -6857.464% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -68.675% |
| argenx SE | 1.1 Billion USD | 99.927% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 103.154% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -31.805% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 99.801% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 9288.629% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 98.165% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 171.283% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 17.636% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 91.533% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 1070.489% |
| BioStem Technologies, Inc. | 15.42 Million USD | 94.724% |
| ONE Bio Corp. | 20.12 Million USD | 95.957% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 6975.75% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 1786.204% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -360.889% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -360.889% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 258.159% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 229.138% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 2906.017% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -80.815% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 354.688% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 82.341% |
| Bioxytran, Inc. | -8285.00 USD | 9921.907% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 318.162% |
| Neutra Corp. | 14.33 Thousand USD | -5576.631% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1092.372% |
| PureTech Health plc | -1.6 Million USD | 150.764% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 181.274% |
| IXICO plc | 3.27 Million USD | 75.115% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 217.254% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 145.435% |
| CSL Limited | 7.7 Billion USD | 99.989% |
| Cellectis S.A. | 18 Thousand USD | -4420.806% |